Sangamo Therapeutics (SGMO) Q2 2026 Earnings

18MayConfirmed
Q3 2025
Q4 2025
Next
Next
-0.11
-0.07
-0.03
0.01

Details

Expected EPS
-0.062433
Actual EPS
N/A
Surprise EPS
0.06
Surprise Percent
+100%

Description

Sangamo Therapeutics (SGMO) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts